Jon Bates - US Physicalrapy VP Controller
| USPH Stock | USD 97.83 0.89 0.92% |
Insider
Jon Bates is VP Controller of US Physicalrapy
| Age | 54 |
| Address | 1300 West Sam Houston Parkway South, Houston, TX, United States, 77042 |
| Phone | 713 297 7000 |
| Web | https://www.usph.com |
Jon Bates Latest Insider Activity
Tracking and analyzing the buying and selling activities of Jon Bates against US Physicalrapy stock is an integral part of due diligence when investing in US Physicalrapy. Jon Bates insider activity provides valuable insight into whether US Physicalrapy is net buyers or sellers over its current business cycle. Note, US Physicalrapy insiders must abide by specific rules, including filing SEC forms every time they buy or sell US Physicalrapy'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Jon Bates over three months ago Acquisition by Jon Bates of 1350 shares of Nutex Health at 21.4589 subject to Rule 16b-3 | ||
Jon Bates over six months ago Acquisition by Jon Bates of 148515 shares of Nutex Health subject to Rule 16b-3 |
US Physicalrapy Management Efficiency
The company has return on total asset (ROA) of 0.0424 % which means that it generated a profit of $0.0424 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0475 %, meaning that it created $0.0475 on every $100 dollars invested by stockholders. US Physicalrapy's management efficiency ratios could be used to measure how well US Physicalrapy manages its routine affairs as well as how well it operates its assets and liabilities. The US Physicalrapy's current Return On Capital Employed is estimated to increase to 0.15, while Return On Tangible Assets are projected to decrease to 0.04. As of now, US Physicalrapy's Total Current Assets are increasing as compared to previous years. The US Physicalrapy's current Non Currrent Assets Other is estimated to increase to about 165.9 K, while Net Tangible Assets are forecasted to increase to (245.4 M).Similar Executives
| Showing other executives | INSIDER Age | ||
| Joel Veit | Select Medical Holdings | N/A | |
| Mat Varghese | agilon health | N/A | |
| FRCPC MD | DaVita HealthCare Partners | N/A | |
| Ravi Sachdev | agilon health | 44 | |
| Christopher Hunter | Acadia Healthcare | 56 | |
| William Wulf | agilon health | 60 | |
| RN MHA | InnovAge Holding Corp | 73 | |
| Terrance Williams | Encompass Health Corp | 52 | |
| Benjamin Kornitzer | agilon health | 42 | |
| Lisa Foo | Tenet Healthcare | 33 | |
| Lisa Dombro | agilon health | 52 | |
| Lynda Smirz | Universal Health Services | N/A | |
| Michelle Gourdine | agilon health | 57 | |
| Mihran Naljayan | DaVita HealthCare Partners | N/A | |
| Derek Bunker | Pennant Group | 36 | |
| Laurence Harrod | Acadia Healthcare | 67 | |
| Andrew Brophy | Healthcare Services Group | 34 | |
| John Winstel | DaVita HealthCare Partners | 53 | |
| Michael Smith | agilon health | 71 | |
| Priscilla Kasenchak | agilon health | 43 | |
| Olivia Patton | InnovAge Holding Corp | N/A | |
Management Performance
| Return On Equity | 0.0475 | ||||
| Return On Asset | 0.0424 |
US Physicalrapy Leadership Team
Elected by the shareholders, the US Physicalrapy's board of directors comprises two types of representatives: US Physicalrapy inside directors who are chosen from within the company, and outside directors, selected externally and held independent of USPH. The board's role is to monitor US Physicalrapy's management team and ensure that shareholders' interests are well served. US Physicalrapy's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, US Physicalrapy's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Chadd Pence, Senior Systems | ||
| PT MBA, Chief West | ||
| Jason Anderson, Vice Resources | ||
| Glenn McDowell, Chief Operating Officer - West | ||
| Jon Bates, VP Controller | ||
| Christopher Reading, President, Chief Executive Officer, Director | ||
| Mark Brookner, Independent Director | ||
| Richard Binstein, Executive Vice President General Counsel, Secretary | ||
| Kathleen Gilmartin, Independent Director | ||
| Edward Kuntz, Independent Chairman of the Board | ||
| Anne Motsenbocker, Director | ||
| Clayton Trier, Independent Director | ||
| Eric Williams, Co-Chief Operating Officer - West | ||
| Graham Reeve, Chief Operating Officer - East | ||
| Bernard Harris, Independent Director | ||
| Reginald Swanson, Director | ||
| Carey Hendrickson, Chief Financial Officer | ||
| ATC PT, VP Officer | ||
| Harry Chapman, Independent Director | ||
| Jake Martinez, Senior Accounting |
USPH Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is US Physicalrapy a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0475 | ||||
| Return On Asset | 0.0424 | ||||
| Profit Margin | 0.04 % | ||||
| Operating Margin | 0.11 % | ||||
| Current Valuation | 1.56 B | ||||
| Shares Outstanding | 15.1 M | ||||
| Shares Owned By Insiders | 1.58 % | ||||
| Shares Owned By Institutions | 98.42 % | ||||
| Number Of Shares Shorted | 597.87 K | ||||
| Price To Earning | 34.35 X |
Currently Active Assets on Macroaxis
When determining whether US Physicalrapy offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of US Physicalrapy's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Us Physicalrapy Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Us Physicalrapy Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in US Physicalrapy. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of US Physicalrapy. If investors know USPH will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about US Physicalrapy listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.24) | Dividend Share 1.75 | Earnings Share 0.88 | Revenue Per Share 42.489 | Quarterly Revenue Growth 0.12 |
The market value of US Physicalrapy is measured differently than its book value, which is the value of USPH that is recorded on the company's balance sheet. Investors also form their own opinion of US Physicalrapy's value that differs from its market value or its book value, called intrinsic value, which is US Physicalrapy's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because US Physicalrapy's market value can be influenced by many factors that don't directly affect US Physicalrapy's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between US Physicalrapy's value and its price as these two are different measures arrived at by different means. Investors typically determine if US Physicalrapy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, US Physicalrapy's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.